374 patienter fik gentagne behandlinger med Macugen i op til 2 år (128 fik 0, 3 mg, 126 fik 1 mg og 120 fik 3 mg).
Three hundred seventy four (374) patients received continuous treatment with Macugen for up to 2 years (128 at 0.3 mg, 126 at 1 mg, and 120 at 3 mg).